All posts
-
Evaxion’s new cancer candidate becomes company’s flagship: “This is not a strategic shift”
Saturday, Evaxion offered its very first information for the business’s crucial brand-new vaccination prospect versus cancer cells.
-
Genmab receives positive phase III results for cancer drug
Epkinly, marketed in Europe as Tekinly, was just recently authorized as a therapy on the United States market.
-
Lundbeck receives positive phase II results for acquired epilepsy drug
Complying with stage II tests, the pharmaceutical business is enthusiastic that bexicaserin will certainly have the ability to assist people with extreme and unusual types of epile…
-
Boehringer Ingelheim continues clinical development of Gubra obesity drug
The medication prospect will certainly currently continue to a stage 2 test.
-
Medtech stock listing implodes in Australia
Saluda Medicals has actually been detailed on the Australian stock market with the most awful lead to years.
-
Eli Lilly obtains subsidy coverage for diabetes drug in China
Novo Nordisk’s Ozempic has actually been qualified for aids on the Chinese market given that 2022.
-
Industry warns: EU agreement on critical medicines could create bureaucracy and hamper innovation
Danish Chamber of Business desires sector to be associated with the execution of the brand-new contract, and both Lif and the Chamber are increasing problems concerning administrat…
-
Investors have sky-high expectations for Eli Lilly
Novo Nordisk experiences a decline in its share price, while Eli Lilly is priced significantly higher due to its success in the weight-loss market.
-
Kroger Shuts Down Automated Grocery Sites in Major Strategy Shift
Kroger is closing down vital Ocado-backed storage facilities, terminating brand-new jobs, and paying $350 million as it moves its on-line grocery store approach.
-
U.S. Offers $134M to Pull Rare Earth Materials From Old Electronics
The United State Power Division is supplying $134 million to assist recuperate unusual planets from waste and decrease international supply dangers.
